Literature DB >> 22744886

A collaborative model for endpoint development for acute bacterial skin and skin structure infections and community-acquired bacterial pneumonia.

Joseph G Toerner, Laurie Burke, Scott Komo, Elektra Papadopoulos.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2012        PMID： 22744886     DOI： 10.1093/cid/cis567

Source DB:  PubMed          Journal:  Clin Infect Dis        ISSN： 1058-4838            Impact factor:   9.079


× No keyword cloud information.
  3 in total

1.  Developing Outcomes Assessments as Endpoints for Registrational Clinical Trials of Antibacterial Drugs: 2015 Update From the Biomarkers Consortium of the Foundation for the National Institutes of Health.

Authors:  George H Talbot; John H Powers; Steven C Hoffmann
Journal:  Clin Infect Dis       Date:  2015-12-13       Impact factor: 9.079

2.  Systematic Review and Meta-Analysis To Estimate Antibacterial Treatment Effect in Acute Bacterial Skin and Skin Structure Infection.

Authors:  Jordan E Cates; Fanny S Mitrani-Gold; Gang Li; Linda M Mundy
Journal:  Antimicrob Agents Chemother       Date:  2015-05-18       Impact factor: 5.191

3.  The Foundation for the National Institutes of Health Biomarkers Consortium: Past Accomplishments and New Strategic Direction.

Authors:  Joseph P Menetski; Steven C Hoffmann; Stephanie S Cush; Tania Nayak Kamphaus; Christopher P Austin; Paul L Herrling; John A Wagner
Journal:  Clin Pharmacol Ther       Date:  2019-04       Impact factor: 6.875
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.